FBLIM1 was reported to promote migration and invasion in glioma (Ou et al., 2017), and participate in brain development and autism spectrum disorders (Kang et al., 2011; Pinto et al., 2014; Ishizuka et al., 2018). Here, FBLIM1 is linked to central nervous system cancer.